• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  IgG4 Fc linked recombinant human alpha-1 antitrypsin
Date Designated:  03/02/2022
Orphan Designation:  Treatment of Alpha-1 Antitrypsin Deficiency
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Inhibrx Inc.
11025 North Torrey Pines Road
Suite 200
La Jolla, California 92037
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.